PORTLAND, Ore. (AP) — Oregon health officials said Thursday that federal officials are investigating the death of a woman in her 50s who developed a rare blood clot and low platelets within two weeks of receiving the Johnson & Johnson vaccine against COVID-19.
The Oregon Health Authority learned of the probe on Tuesday, two days after the U.S. Centers for Disease Control and Prevention began the investigation, the agency said. The woman, whose name was not released, received the dose before the CDC ordered a pause on the vaccine amid concerns it could cause dangerous clots.
The woman developed a “rare but serious blood clot in combination with very low platelets,” OHA said in a statement.
Health officials did not release any further details, including the date the woman got the vaccine or where in Oregon she lived.
Until the investigation is complete, it’s not certain that her death is related to the vaccine, the agency said.
Federal and state agencies paused the J&J vaccine rollout on April 13 due to concerns about blood clots.
Federal officials already were examining six reports of the unusual clots, including a death, out of more 8 million Americans given the one-dose vaccination so far. The CDC also told Texas health authorities Thursday that a woman in that state was hospitalized with possible blood clots associated with J&J vaccine recipients.
A government advisory committee on vaccines is expected to meet Friday and could make a recommendation soon after on whether and how to resume use of the J&J vaccine.
Copyright © 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.